Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of the NormaTec PCD in the Treatment of Diabetic Peripheral Neuropathy

NCT01175928 is registered in ClinicalTrials.gov with NormaTec Industries LP as lead sponsor.

NCT NCT01175928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01175928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of the NormaTec PCD in the Treatment of Diabetic Peripheral Neuropathy
Lead sponsor
NormaTec Industries LP
Phase
Phase 1/2
Overall status
Unknown status
Start date
October 31, 2010
Completion date
September 30, 2012
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic polyneuropathy